Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study

Published:2016-04-08 Issue:6 Volume:55 Page:734-741
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ahern Thomas P.¹,Cronin-Fenton Deirdre P.²,Lash Timothy L.²³,Sørensen Henrik Toft²,Ording Anne Gulbech²,Hamilton-Dutoit Stephen J.⁴,Hellberg Ylva⁴⁵

Affiliation:

1. Department of Surgery, University of Vermont College of Medicine, Burlington, Vermont, USA;

2. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;

3. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA;

4. Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark;

5. Department of Pathology, Hvidovre Hospital, Hvidovre Municipality, Denmark

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2016.1150606

Reference33 articles.

1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

2. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

3. PAK1 as a therapeutic target

4. Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p21 activated kinase-1 and tamoxifen – A deadly nexus impacting breast cancer outcomes;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-01

2. Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis;Discover Oncology;2021-10-01

3. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A2 (sPLA2) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells;International Journal of Molecular Sciences;2020-12-10

4. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study;Acta Oncologica;2018-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3